| 摘要 |
PURPOSE: To obtain a pergolide compound-containing pharmaceutical composition that has strong dopamine activity and is stabilized to photodegradation useful for treatment of a hyperprolactin blood disease. CONSTITUTION: This pergolide compound-containing pharmaceutical composition suitable for oral administration contains pergolide and its salts as an active ingredient, a stabilizer selected from polyvinyl pyrrolidone,α-tocopherol succinate and propyl gallate, and one or more excipients. When polyvinyl pyrrolidone is used for this composition, it is added in a quantity of 0.3-2wt.% to the whole weight of the composition.
|
